As shown in Figure 6B, NFE2L3 mutations occurred in most tumor types, with the top three tumors, UCEC, BLCA, and ESCA, having high NFE2L3 mutations (>6%). The gene discussed is NFE2L3; the disease is bladder transitional cell carcinoma.